Clinical Trial Update: Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating Enavogliflozin versus Pioglitazone to assess glucose control and effects on atherosclerosis in patients with Type 2 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Enavogliflozin (enavogliflozin)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Type 2 Diabetes | Phase 4 | Status: RECRUITING